Background: Postmarketing research has explored the optimal application schedule of
imiquimod 5% cream for treatment of external anogenital warts. Objectives: We systemically …

Background: Interferon in a variety of topical, interlesional, and parenteral preparations has
been used for condylomata acuminata (CA) in HIV negative patients. Study goals: This open …

BACKGROUND: HIV-positive patients have unpredictable local immune responses even
with severe systemic immunosuppression and data reported to date is insufficient to predict …

This is a new book on the integrated management of vulvovaginal disease. The authors
come from a variety of backgrounds-gynaecology, dermatology, pathology and psychology …

Dos diversos tratamentos da infecção anal pelo papilomavírus humano, uma opção é o
imunomodulador imiquimode. Derivado da família imidazoquinolina, o imiquimode é …

Background Condylomata acuminata of the anal canal, a common sexually transmitted
disease, are difficult‐to‐treat lesions with a high recurrence rate after initial successful …

INTRODUCTION: Imiquimod is a topical chemotherapic and immunostimulant agent with
antitumoral and antiviral activities, used for anal condylomata acuminata treatment, mainly in …

Hintergrund Regelmäßige proktologische Untersuchungen sind bei HIV+-Patienten
aufgrund häufiger anorektaler Erkrankungen erforderlich. Insbesondere HPV-assoziierte …

Genital warts are a sexually transmitted disease with high prevalence in the US Imiquimod
5% cream is a self-applied treatment, prescribed three-times weekly, at bedtime, for 16 …